CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: myo-inositol hexakisphosphate
Accession: CHEBI:17401
browse the term
Definition: A myo-inositol hexakisphosphate in which each hydroxy group of myo-inositol is monophosphorylated.
Synonyms: exact_synonym: myo-inositol hexakis(dihydrogen phosphate)
related_synonym: 1D-myo-Inositol 1,2,3,4,5,6-hexakisphosphate; 1D-myo-Inositol hexakisphosphate; D-myo-Inositol 1,2,3,4,5,6-hexakisphosphate; Formula=C6H18O24P6; InChI=1S/C6H18O24P6/c7-31(8,9)25-1-2(26-32(10,11)12)4(28-34(16,17)18)6(30-36(22,23)24)5(29-35(19,20)21)3(1)27-33(13,14)15/h1-6H,(H2,7,8,9)(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)(H2,19,20,21)(H2,22,23,24)/t1-,2-,3-,4+,5-,6-; InChIKey=IMQLKJBTEOYOSI-GPIVLXJGSA-N; Inosithexaphosphorsaeure; Phytate; Phytic acid; Phytine; SMILES=OP(O)(=O)O[C@@H]1[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H]1OP(O)(O)=O; Saeure des phytins; acide fytique; acido fitico; acidum fyticum; myo-inositol 1,2,3,4,5,6-hexakisphosphate
alt_id: CHEBI:10603; CHEBI:11366; CHEBI:12829; CHEBI:12832; CHEBI:19200
xref: Beilstein:2201952; CAS:83-86-3; Drug_Central:3465; KEGG:C01204
xref_mesh: MESH:D010833
xref: MetaCyc:HEXAKISPHOSPHATE; PMID:11217149; PMID:11545369; PMID:12070948; PMID:12162428; PMID:12816787; PMID:12949395; PMID:15325752; PMID:15743020; PMID:15918884; PMID:15952339; PMID:15998131; PMID:16438310; PMID:17162330; PMID:18536177; PMID:19331859; PMID:21292245; PMID:22023391; PMID:6095072; Reaxys:2201952; Wikipedia:Phytic_acid
cyclic_relationship: is_conjugate_acid_of CHEBI:58130
G
Akt1
AKT serine/threonine kinase 1
decreases activity
ISO
Phytic Acid results in decreased activity of AKT1 protein
CTD
PMID:15868430
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Casp3
caspase 3
multiple interactions
ISO
Phytic Acid inhibits the reaction [Asbestos, Amosite results in increased activity of CASP3 protein]
CTD
PMID:11329530
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
multiple interactions
ISO
Phytic Acid inhibits the reaction [Asbestos, Amosite results in increased activity of CASP9 protein]
CTD
PMID:12540492 PMID:14766669
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions
EXP
[Phytic Acid co-treated with Inositol] inhibits the reaction [Streptozocin results in decreased activity of CAT protein]
CTD
PMID:28757134
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccnd1
cyclin D1
multiple interactions
ISO
Phytic Acid inhibits the reaction [Urethane results in increased expression of CCND1 mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of CCND1 protein]
CTD
PMID:22797328
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
decreases expression
ISO
Phytic Acid results in decreased expression of CDKN1B protein
CTD
PMID:15868430
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
multiple interactions affects methylation
ISO
Phytic Acid inhibits the reaction [Ethylnitrosourea results in decreased expression of CDKN2A] Phytic Acid affects the methylation of CDKN2A promoter
CTD
PMID:21154115
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
G
Egfr
epidermal growth factor receptor
multiple interactions
ISO
Phytic Acid inhibits the reaction [Asbestos, Crocidolite results in decreased phosphorylation of EGFR protein]
CTD
PMID:15626777
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Ehmt2
euchromatic histone lysine methyltransferase 2
multiple interactions
ISO
Phytic Acid inhibits the reaction [Urethane results in increased expression of EHMT2 mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of EHMT2 protein]
CTD
PMID:25168426
NCBI chr20:3,919,623...3,936,751
Ensembl chr20:3,919,624...3,941,547
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
multiple interactions
ISO
Phytic Acid inhibits the reaction [Urethane results in increased expression of EZH2 mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of EZH2 protein]
CTD
PMID:25168426
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
G
Foxo1
forkhead box O1
multiple interactions
ISO
[resveratrol co-treated with Quercetin co-treated with Phytic Acid] results in increased expression of FOXO1 mRNA
CTD
PMID:18657603
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
G
G6pd
glucose-6-phosphate dehydrogenase
multiple interactions
EXP
[Phytic Acid co-treated with Inositol] inhibits the reaction [Streptozocin results in decreased activity of G6PD protein]
CTD
PMID:28757134
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Il6
interleukin 6
multiple interactions
ISO
Phytic Acid inhibits the reaction [Urethane results in increased expression of IL6 mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of IL6 protein]
CTD
PMID:22797328
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Mapk1
mitogen activated protein kinase 1
decreases activity multiple interactions
ISO EXP
Phytic Acid results in decreased activity of MAPK1 protein [resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased phosphorylation of MAPK1 protein
CTD
PMID:15868430 PMID:21203465
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
decreases activity multiple interactions
ISO EXP
Phytic Acid results in decreased activity of MAPK3 protein [resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased phosphorylation of MAPK3 protein
CTD
PMID:15868430 PMID:21203465
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mir101a
microRNA 101a
multiple interactions
EXP
[resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased expression of MIR101A mRNA
CTD
PMID:21203465
NCBI chr 5:115,966,332...115,966,406
Ensembl chr 5:115,966,328...115,966,410
G
Mir10a
microRNA 10a
multiple interactions
EXP
[resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased expression of MIR10A mRNA
CTD
PMID:21203465
NCBI chr10:81,283,171...81,283,280
Ensembl chr10:81,283,171...81,283,280
G
Mir138-1
microRNA 138-1
multiple interactions
ISO
Phytic Acid inhibits the reaction [Urethane results in decreased expression of MIR138-1 mRNA]
CTD
PMID:25168426
NCBI chr 8:122,300,966...122,301,064
Ensembl chr 8:122,300,966...122,301,064
G
Mir181c
microRNA 181c
multiple interactions
EXP
[resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased expression of MIR181C mRNA
CTD
PMID:21203465
NCBI chr19:23,983,523...23,983,628
Ensembl chr19:23,983,523...23,983,628
G
Mir20b
microRNA 20b
multiple interactions
EXP
[resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in decreased expression of MIR20B mRNA
CTD
PMID:21203465
NCBI chr X:132,422,211...132,422,282
Ensembl chr X:132,422,211...132,422,282
G
Mir21
microRNA 21
multiple interactions
EXP
[resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased expression of MIR21 mRNA
CTD
PMID:21203465
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
G
Mir214
microRNA 214
multiple interactions
EXP
[Resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased expression of MIR214 mRNA
CTD
PMID:21203465
NCBI chr13:74,588,374...74,588,481
Ensembl chr13:74,588,372...74,588,481
G
Mir25
microRNA 25
multiple interactions
EXP
[resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased expression of MIR25 mRNA
CTD
PMID:21203465
NCBI chr12:17,042,932...17,043,015
Ensembl chr12:17,042,932...17,043,015
G
Mir27b
microRNA 27b
multiple interactions
EXP
[resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in decreased expression of MIR27B mRNA
CTD
PMID:21203465
NCBI chr17:1,813,427...1,813,523
Ensembl chr17:1,813,426...1,813,529
G
Mir324
microRNA 324
multiple interactions
EXP
[resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased expression of MIR324 mRNA
CTD
PMID:21203465
NCBI chr10:54,734,680...54,734,762
Ensembl chr10:54,734,678...54,734,766
G
Mir339
microRNA 339
multiple interactions
EXP
[resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased expression of MIR339 mRNA
CTD
PMID:21203465
NCBI chr12:15,277,546...15,277,641
Ensembl chr12:15,277,546...15,277,641
G
Mir450a1
microRNA 450a-1
multiple interactions
EXP
[resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased expression of MIR450A1 mRNA
CTD
PMID:21203465
NCBI chr X:132,801,380...132,801,470
Ensembl chr X:132,801,380...132,801,470
G
Mir760
microRNA 760
multiple interactions
EXP
[resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased expression of MIR760 mRNA
CTD
PMID:21203465
NCBI chr 2:210,392,616...210,392,695
Ensembl chr 2:210,392,616...210,392,695
G
Mlh1
mutL homolog 1
multiple interactions affects methylation
ISO
Phytic Acid inhibits the reaction [Ethylnitrosourea results in increased expression of MLH1] Phytic Acid affects the methylation of MLH1 promoter
CTD
PMID:21154115
NCBI chr 8:111,196,468...111,233,721
Ensembl chr 8:111,196,468...111,233,617
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO
Phytic Acid inhibits the reaction [Urethane results in decreased expression of NFKB1 mRNA]; Phytic Acid inhibits the reaction [Urethane results in decreased expression of NFKB1 protein]; Phytic Acid inhibits the reaction [Urethane results in increased expression of NFKB1 mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of NFKB1 protein]
CTD
PMID:22797328
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
Phytic Acid inhibits the reaction [Asbestos, Amosite results in increased activity of PARP1 protein]; Phytic Acid inhibits the reaction [Smoke analog results in increased activity of PARP1 protein]
CTD
PMID:11217149
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pdk4
pyruvate dehydrogenase kinase 4
multiple interactions
ISO
[resveratrol co-treated with Quercetin co-treated with Phytic Acid] results in increased expression of PDK4 mRNA
CTD
PMID:18657603
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
G
Ppargc1a
PPARG coactivator 1 alpha
multiple interactions
ISO
[resveratrol co-treated with Quercetin co-treated with Phytic Acid] results in increased expression of PPARGC1A mRNA
CTD
PMID:18657603
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Prkcd
protein kinase C, delta
multiple interactions
ISO
Phytic Acid results in increased expression of and results in increased activity of and affects the localization of PRKCD protein
CTD
PMID:15868430
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions affects methylation
ISO
Phytic Acid inhibits the reaction [Ethylnitrosourea results in increased expression of PTGS2]; Phytic Acid inhibits the reaction [Urethane results in increased expression of PTGS2 mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of PTGS2 protein] Phytic Acid affects the methylation of PTGS2 promoter
CTD
PMID:21154115 PMID:22797328
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rb1
RB transcriptional corepressor 1
decreases phosphorylation
ISO
Phytic Acid results in decreased phosphorylation of RB1 protein
CTD
PMID:15868430
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
Phytic Acid inhibits the reaction [Urethane results in increased expression of RELA mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of RELA protein]
CTD
PMID:22797328
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Stat3
signal transducer and activator of transcription 3
multiple interactions
ISO
Phytic Acid inhibits the reaction [Urethane results in increased expression of and results in increased phosphorylation of STAT3 protein]; Phytic Acid inhibits the reaction [Urethane results in increased expression of STAT3 mRNA]
CTD
PMID:22797328
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Suv39h1
SUV39H1 histone lysine methyltransferase
multiple interactions
ISO
Phytic Acid inhibits the reaction [Urethane results in increased expression of SUV39H1 mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of SUV39H1 protein]
CTD
PMID:25168426
NCBI chr X:14,421,028...14,433,993
Ensembl chr X:14,421,109...14,433,982
G
Suv39h1-ps1
SUV39H1 histone lysine methyltransferase, pseudogene 1
multiple interactions
ISO
Phytic Acid inhibits the reaction [Urethane results in increased expression of SUV39H1 mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of SUV39H1 protein]
CTD
PMID:25168426
NCBI chr X:141,792,589...141,795,257
G
Tp53
tumor protein p53
multiple interactions
ISO EXP
Phytic Acid inhibits the reaction [Asbestos, Amosite results in increased expression of TP53 mRNA]; Phytic Acid inhibits the reaction [Asbestos, Amosite results in increased expression of TP53 protein]
CTD
PMID:16357363
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Ucp3
uncoupling protein 3
multiple interactions
ISO
[resveratrol co-treated with Quercetin co-treated with Phytic Acid] results in increased expression of UCP3 mRNA
CTD
PMID:18657603
NCBI chr 1:154,815,777...154,828,764
Ensembl chr 1:154,815,777...154,828,762
G
Xdh
xanthine dehydrogenase
decreases activity
EXP
Phytic Acid results in decreased activity of XDH protein
CTD
PMID:14738912
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all